Study of Goodphyte IB Defense and Goodphyte Immunity Supplements on Iron and Zinc Absorption in Adults with Chronic Diseases Including Crohns Disease, Ulcerative Colitis, Hypertension, Anemia, and Multiple Sclerosis

What this Trial Is About

This research aims to evaluate how well adult individuals with chronic diseases such as Crohns disease, Ulcerative Colitis, Arterial Hypertension, Anemia, or Multiple Sclerosis accept and adhere to two dietary supplements containing microbial phytase, called Goodphyte IB Defense and Goodphyte Immunity. The study also investigates potential changes in the absorption of iron and zinc after phytase supplementation and how these changes might affect participants quality of life. Participants will be randomly assigned to receive one of the two dietary supplements, Goodphyte IB Defense or Goodphyte Immunity. Each participant will take four capsules daily for two weeks. The study focuses on evaluating the acceptability and adherence to these supplements during this intervention period. Throughout the study, participants will complete questionnaires to assess acceptability and adherence immediately after the two-week intervention. Researchers will measure changes in serum iron, zinc, ferritin, inflammatory markers, quality of life, fatigue, body mass index, and disease-specific scores at baseline, mid-intervention, and after completion. The total participation lasts for two weeks, during which detailed clinical and quality of life evaluations will be made to understand the supplements effects on these chronic conditions.

Acceptability, Adherence, and Impact on the Bioavailability of Iron and Zinc of the Dietary Supplements Goodphyte IB Defense and Goodphyte Immunity in Adults With Chronic Diseases.